GlassScriptPhysician profile
Larry M Newman
NPI 1023003902
$618.04
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $344 · 2020: $274.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $257.85 | 2020 | |
| Keswick Pharmaceuticals LLC | $129.28 | 2019 | |
| Dynasplint Systems INC. | $56.31 | 2019 | |
| Celgene Corporation | $46.72 | 2019 | |
| Sebela Pharmaceuticals INC. | $43.63 | 2019 | |
| Alexion Pharmaceuticals, INC. | $32.91 | 2019-2020 | |
| Polarityte, INC. | $22.14 | 2019 | |
| Kerecis Limited | $14.84 | 2019 | |
| Misonix INC | $14.36 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larry Newman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.